Knowles Jonathan Kenneth Charles - Net Worth and Insider Trading

Knowles Jonathan Kenneth Charles Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Knowles Jonathan Kenneth Charles owns 1 companies in total, including Adaptimmune Therapeutics PLC (ADAP) .

Click here to see the complete history of Knowles Jonathan Kenneth Charles’s form 4 insider trades.

Insider Ownership Summary of Knowles Jonathan Kenneth Charles

Ticker	Company	Transaction Date	Type of Owner
ADAP	Adaptimmune Therapeutics PLC	2016-01-01	director

Knowles Jonathan Kenneth Charles Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Knowles Jonathan Kenneth Charles Ownership Network

Ownership Network List of Knowles Jonathan Kenneth Charles

No Data

Ownership Network Relation of Knowles Jonathan Kenneth Charles

Knowles Jonathan Kenneth Charles Owned Company Details

What does Adaptimmune Therapeutics PLC do?

Who are the key executives at Adaptimmune Therapeutics PLC?

Knowles Jonathan Kenneth Charles is the director of Adaptimmune Therapeutics PLC. Other key executives at Adaptimmune Therapeutics PLC include Chief Medical Officer Elliot Norry , Chief Operating Officer Bertrand William C Jr , and Chief Patient Supply Officer John Lunger .

Adaptimmune Therapeutics PLC (ADAP) Insider Trades Summary

Over the past 18 months, Knowles Jonathan Kenneth Charles made no insider transaction in Adaptimmune Therapeutics PLC (ADAP). Other recent insider transactions involving Adaptimmune Therapeutics PLC (ADAP) include a net sale of 90,170 shares made by Adrian Rawcliffe , a net sale of 37,522 shares made by Cintia Piccina , and a net sale of 27,779 shares made by Elliot Norry .

In summary, during the past 3 months, insiders sold 0 shares of Adaptimmune Therapeutics PLC (ADAP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 205,723 shares of Adaptimmune Therapeutics PLC (ADAP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 205,723 shares.

Adaptimmune Therapeutics PLC (ADAP)'s detailed insider trading history can be found in Insider Trading Tracker table.

Adaptimmune Therapeutics PLC Insider Transactions

No Available Data

Knowles Jonathan Kenneth Charles Mailing Address

Above is the net worth, insider trading, and ownership report for Knowles Jonathan Kenneth Charles. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Knowles Jonathan Kenneth Charles's mailing address is: Baselland V8 Ch 4102.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.